NCT02717221View on ClinicalTrials.gov

In Vivo EGFR Molecular Classification and Treatment Response

NACompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2019

Study Completion Date

December 31, 2019

Conditions
Molecular Imaging
Interventions
OTHER

18F-MPG

N-(3-chloro-4-fluorophenyl)-7-(2-(2-(2-(2-\[18F\] fluoroethoxy) ethoxy) ethoxy) ethoxy)-6-methoxyquinazolin-4-amine (18F-MPG)

Trial Locations (1)

150028

TOF-PET/CT/MR center of the Fourth Hospital of Harbin Medical University, Harbin

All Listed Sponsors
lead

Harbin Medical University

OTHER

NCT02717221 - In Vivo EGFR Molecular Classification and Treatment Response | Biotech Hunter | Biotech Hunter